Thrombotic events in patients with congenital prekallikrein deficiency: A critical evaluation of all reported cases

Acta Haematologica

Volumn 123, Issue 4, 2010, Pages 210-214

  Girolami, A ^a,c   Allemand, E ^a   Bertozzi, I ^a   Candeo, N ^a   Marun, S ^a   Girolami, B ^b  

^a UNIVERSITY OF PADUA MEDICAL SCHOOL   (Italy)

^b Padua City Hospital   (Italy)

^c Department of Medical and Surgical Sciences   (Italy)

Author keywords

Clotting defect; Prekallikrein deficiency; Thrombosis

Indexed keywords

BLOOD CLOTTING FACTOR 7; COUMARIN; HEPARIN; PREKALLIKREIN;

ADULT; ARTERY THROMBOSIS; ARTICLE; BLOOD CLOTTING; BLOOD CLOTTING FACTOR DEFICIENCY; BRAIN ISCHEMIA; CLINICAL FEATURE; CONTROLLED STUDY; DEEP VEIN THROMBOSIS; DISEASE SEVERITY; FEMALE; HEART INFARCTION; HUMAN; LUNG EMBOLISM; MAJOR CLINICAL STUDY; MALE; OUTCOME ASSESSMENT; PREKALLIKREIN DEFICIENCY; PRIORITY JOURNAL; RISK FACTOR; VEIN THROMBOSIS;

ADULT; BLOOD COAGULATION; BLOOD COAGULATION DISORDERS, INHERITED; FEMALE; HUMANS; MALE; MIDDLE AGED; PREKALLIKREIN; THROMBOSIS;

EID: 77951251161     PISSN: 00015792     EISSN: None     Source Type: Journal    
DOI: 10.1159/000313361     Document Type: Article

References (47)

1. Girolami A, Ruzzon E, Fabris F, Varvarikis C, Sartori R, Girolami B: Myocardial infarction and other arterial occlusions in hemophilia A patients. A cardiological evaluation of all 42 cases reported in the literature. Acta Haematol 2006; 116: 120-125.
2. Girolami A, Randi ML, Ruzzon E, Zanon E, Girolami B: Myocardial infarction, other arterial thrombosis and invasive coronary procedures, in hemaophilia B: a critical evaluation of reported cases. J Thromb Thrombolysis 2005; 20: 43-46.
3. Goodnough LT, Saito H, Ratnoff OD: Thrombosis or myocardial infarction in congenital clotting factor abnormalities and chronic thrombocytopenias: a report of 21 patients and a review of 50 previously reported cases. Medicine (Baltimore) 1983; 62: 248-255.
4. Girolami A, Scandellari R, Zanon E, Sartori R, Girolami B: Non-catheter associated venous thrombosis in hemophilia A and B. A critical review of all reported cases. J Thromb Thrombolysis 2006; 21: 279-284.
5. Girolami A, Tezza F, Scapin M, Vettore S, Casonato A: Arterial and venous thrombosis in patients with von Willebrand's disease: a critical review of the literature. J Thromb Thrombolysis 2006; 21: 175-178.
6. Girolami A, Ruzzon E, Tezza F, Scandellari R, Vettore S, Girolami B: Arterial and venous thrombosis in rare congenital bleeding disorders: a critical review. Haemophilia 2006; 12: 345-351.
7. Ratnoff OD, Busse RJ, Sheon RP: The demise of John Hageman. N Engl J Med 1968; 279: 760-761.
8. Zeerleder S, Schloesser M, Redondo M, Wuillemin WA, Engel W, Furlan M, Lämmle B: Reevaluation of the incidence of thromboembolic complications in congenital factor XII deficiency - a study on 73 subjects from 14 Swiss families. Thromb Haemost 1999; 82: 1240-1246.
9. Girolami A, Morello M, Girolami B, Lombardi AM, Bertolo C: Myocardial infarction and arterial thrombosis in severe (homozygous) FXII deficiency: no apparent causative relation. Clin Appl Thromb Hemost 2005; 11: 49-53.
10. Acar K, Yaǧci M, Sucak GT, Haznedar R: Isolated prolonged activated partial thromboplastin time in an asymptomatic patient: Fletcher factor deficiency. Thromb Res 2006; 118: 765-766.
11. Asmis LM, Sulzer I, Furlan M, Lämmle B: Prekallikrein deficiency: the characteristic normalization of the severely prolonged aPTT following increased preincubation time is due to autoactivation of factor XII. Thromb Res 2002; 105: 463-470.
12. Aznar JA, España F, Aznar J, Tascon A, Jimenez C. Fletcher factor deficiency: report of a new family. Scand J Haematol 1978; 21: 94-98.
13. Bouma BN, Kerbiriou DM, Baker J, Griffin JH: Characterization of a variant prekallikrein, prekallikrein Long Beach, from a family with mixed cross-reacting material-positive and cross-reacting material-negative prekallikrein deficiency. J Clin Invest 1986; 78: 170-176.
14. Castaman G, Ruggeri M, Rodeghiero F: A new Italian family with severe prekallikrein deficiency. Desmopressin-induced fibrinolysis and coagulation changes in homozygous and heterozygous members. Ric Clin Lab 1990; 20: 239-244.
15. Colla G, Carrea M, Sbaffi A. Fletcher factor deficiency (report of a new case). Ric Clin Lab 1983; 13: 443-448.
16. Currimbhoy Z, Vinciguerra V, Palakavongs P, Kuslansky P, Degnan TJ. Fletcher factor deficiency and myocardial infarction. Am J Clin Pathol 1976; 65: 970-974.
17. DeLa Cadena RA: Fletcher factor deficiency in a 9-year-old girl: mechanisms of the contact pathway of blood coagulation. Am J Hematol 1995; 48: 273-277.
18. De Stefano V, Leone G, Teofili L, De Marinis L, Micalizzi P, Fiumara C, Bizzi B: Association of Graves' disease and prekallikrein congenital deficiency in a patient belonging to the first CRM+ prekallikrein-deficient Italian family. Thromb Res 1990; 60: 397-404.
19. Dietzel H, Lutze G, Kätzel R, Liebscher K: Präkallikrein- (Fletcher-Faktor-)Defekt als Ursache einer präoperativen APTT-Verlängerung. Med Klin (Munich) 2003; 98: 587-590. (Pubitemid 37328312)
20. Entes K, LaDuca FM, Tourbaf KD. Fletcher factor deficiency, source of variations of the activated partial thromboplastin time test. Am J Clin Pathol 1981; 75: 626-628.
21. Ferrières J, Cambou JP, Ruidavets JB, Pous J: Trends in acute myocardial infarction prognosis and treatment in southwestern France between 1985 and 1990 (the MONICA Project- Toulouse). Am J Cardiol 1995; 75: 1202-1205.
22. François D, Trigui N, Leterreux G, Flaujac C, Horellou MH, Mazaux L, Vignon D, Conard J, de Mazancourt P: Severe prekallikrein deficiencies due to homozygous C529Y mutations. Blood Coagul Fibrinolysis 2007; 18: 283-286.
23. Girolami A, Marun S, Vettore S, Scaliter G, Molina A, Scarparo P, Tabares A, Lombardi AM: A large family from Argentina with Prekallikrein deficiency due to a compound heterozygosis (T insertion in intron 7 and Asp558Glu in exon 15): Prekallikrein Cordoba. Am J Hematol DOI: 10.1002/ajh21654.
24. Harris MG, Exner T, Rickard KA, Kronenberg H: Multiple cerebral thrombosis in Fletcher factor (prekallikrein) deficiency: a case report. Am J Hematol 1985; 19: 387-393.
25. Hathaway WE, Belhasen LP, Hathaway HS: Evidence for a new plasma thromboplastin factor. I. Case report, coagulation studies and physicochemical properties. Blood 1965; 26: 521-532.
26. Hathaway WE, Wuepper KD, Weston WL, Humbert JR, Rivers RP, Genton E, August CS, Montgomery RR, Mass MF: Clinical and physiologic studies of two siblings with prekallikrein (Fletcher factor) deficiency. Am J Med 1976; 60: 654-664.
27. Hattersley PG, Hayse D: Fletcher factor deficiency: a report of three unrelated cases. Br J Haematol 1970; 18: 411-416.
28. Hess DC, Krauss JS, Rardin D: Stroke in a young adult with Fletcher trait. South Med J 1991; 84: 507-508.
29. Isobe J: Prekallikrein deficiency (Fletcher trait) (in Japanese). Ryoikibetsu Shokogun Shirizu 1998; 21: 468-470.
30. Joggi J, Stalder M, Knecht H, Hauert J, Bachmann F: Déficience en prékallicréine: à propos de 2 cas. Schweiz Med Wochenschr 1990; 120: 1942-1944.
31. Jones DW, Russell G, Allford SL, Burdon K, Hawkins GA, Bowden DW, Minaee S, Mumford AD: Severe prekallikrein deficiency associated with homozygosity for an Arg- 94Stop nonsense mutation. Br J Haematol 2004; 127: 220-223.
32. Katsuda I, Maruyama F, Ezaki K, Sawamura T, Ichihara Y: A new type of plasma prekallikrein deficiency associated with homozygosity for Gly104Arg and Asn124Ser in apple domain 2 of the heavy-chain region. Eur J Haematol 2007; 79: 59-68.
33. Kolodie L, Poirot P, Foret C: Un cas de déficit en facteur Fletcher. Nouv Rev Fr 1980; 22: 89-90.
34. Kyrle PA, Niessner H, Deutsch E, Lechner K, Korninger C, Mannhalter C: CRM+ severe Fletcher factor deficiency associated with Graves' disease. Haemostasis 1984; 14: 302-306.
35. Lombardi AM, Sartori MT, Cabrio L, Fadin M, Zanon E, Girolami A: Severe prekallikrein (Fletcher factor) deficiency due to a compound heterozygosis (383Trp stop codon and Cys529Tyr). Thromb Haemost 2003; 90: 1040-1045.
36. Nagaya S, Morishita E, Takami A, Maruyama K, Sekiya A, Asakura H, Nakao S, Ohtake S: An elderly case of congenital prekallikrein deficiency. Nippon Ronen Igakkai Zasshi 2009; 46: 348-351.
37. Odumosu MC, Yoong WC, Fakokunde AF: Fletcher factor deficiency in a woman requiring emergency caesarean section. J Obstet Gynaecol 2009; 29: 442.
38. Oram MP, Mumford AD, Morse C, Underwood S: Management of anticoagulation for coronary artery bypass surgery in a patient with severe prekallikrein deficiency. J Cardiothorac Vasc Anesth 2006; 20: 580-582.
39. Pasricha SK, Weiss H, Chen A: Spinal anesthesia in a patient with prekallikrein deficiency. Anesth Analg 1996; 83: 1325-1326.
40. Poon MC, Moore MR, Castleberry RP, Lurie A, Huang ST, Lehmeyer J: Severe Fletcher factor (plasma prekallikrein) deficiency with partial deficiency of Hageman factor (factor XII): report of a case with observation on in vivo and in vitro leukocyte chemotaxis. Am J Hematol 1982; 12: 261-270.
41. Raffoux C, Alexandre P, Perrier P, Briquel ME, Streiff F: HLA typing in a new family with Fletcher factor deficiency. Hum Genet 1982; 60: 71-73.
42. Saade M: Fletcher factor deficiency with mildly prolonged activated PTT. South Med J 1980; 73: 958.
43. Saito H, Goodnough LT, Soria J, Soria C, Aznar J, España F: Heterogeneity of human prekallikrein deficiency (Fletcher trait): evidence that five of 18 cases are positive for cross-reacting material. N Engl J Med 1981; 305: 910-914.
44. Shigekiyo T, Fujino O, Kanagawa Y, Matsumoto T: Prekallikrein (PK) Tokushima: PK deficiency caused by a Gly401 ] Glu mutation. J Thromb Haemost 2003; 1: 1314-1316.
45. Sollo DG, Saleem A: Prekallikrein (Fletcher factor) deficiency. Ann Clin Lab Sci 1985; 15: 279-285.
46. Waddell CC, Brown JA, Udden MM: Plasma prekallikrein (Fletcher factor) deficiency in a patient with chronic lymphocytic leukemia. South Med J 1980; 73: 1653-1655.
47. Wuillemin WA, Furlan M, von Felten A, Lämmle B: Functional characterization of a variant prekallikrein (PK Zurich). Thromb Haemost 1993; 70: 427-432.